Articles

Expert insights and practical perspectives on drug safety.

Read the latest Qinecsa articles and partner contributions covering pharmacovigilance, clinical safety, signal and risk management, and regulatory topics.

The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?

July 28, 2026

Embracing quantitative signal detection methods as a smaller MAH

June 25, 2026

Real-Time Safety Signals Drive Continuous PV Insight

May 27, 2026

From Complaint Handling to Active Surveillance

May 5, 2026

Continuous Safety Surveillance for Medical Devices

May 5, 2026

Are patient outcomes getting lost in safety data complexity?

May 5, 2026

From data collection to interrogation: why 2026 is the inflection point for combination product safety surveillance

April 30, 2026

Weight of the world: are GLP-1s breaking PV?

April 29, 2026

Making an Impact Beena Wood

April 29, 2026

Regulators must intervene to drive up the quality and impact of patient safety reporting

April 29, 2026

Predicting the present What’s topping pharma’s strategic agenda for 2026?

April 29, 2026

How AI is Transforming the Biopharmaceutical Value Chain

April 3, 2026

Could GLP-1 obesity drugs break pharma’s safety infrastructure?

March 3, 2026

Solving safety data complexity is not an AI quick-fix

February 23, 2026

Building the Foundations for Proactive Drug Safety

February 11, 2026

Why Data, Trust, and Skills Are the Foundations of AI-Driven Pharmacovigilance

February 11, 2026

Realizing the Potential of AI within the PV

February 11, 2026

Bio/Pharma’s Roadmap for Success in 2026

February 11, 2026

Being is believing

February 11, 2026

Pharma’s operational imperatives for 2026: what next for AI, data and connected information delivery?

January 29, 2026

Improved Drug Safety Needs Better Data Before AI

January 23, 2026

Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization

January 6, 2026

Leaders in Pharma: 2026 predictions

December 16, 2025

The Indisputable Case for AI in Pharmacovigilance

December 12, 2025

Digital Transformation Themes of 2025

December 8, 2025

That was the year that was

December 4, 2025

Democratising access to signal detection

November 19, 2025

Applying AI to adverse event case processing

October 15, 2025

How smaller pharma teams are rethinking safety surveillance

September 22, 2025

Statistical Significance: Could Small Pharma make more of Signal Detection

September 19, 2025

Staying Ahead of Regulatory Revisions

September 17, 2025

A Critical Inflection Point: The Indisputable Case for Next-Gen Pharmacovigilance

September 12, 2025

AI Encompassing: From Soaring Caseloads to Broadened Biopharma Territory

September 12, 2025

Human and Machine: A New Standard in Pharmacovigilance

September 12, 2025

Powering the Pharmacovigilance Engine: Why AI’s Role is Pivotal Now

August 5, 2025

Qinecsa CEO featured in the Molecule to Market podcast

July 25, 2025

From Weight-loss Jabs to Ongoing Covid Vaccine Vigilance

July 14, 2025

Harnessing Technology to Optimize Pharmacovigilance

May 23, 2025

Fit-for-Purpose Signal Detection Solutions for Pharmacovigilance

May 12, 2025

Building an Automation and AI Culture

April 24, 2025

A Five-Year Roadmap for Technology-led PV Innovation

April 15, 2025

Navigating Drug Safety Challenges in Small Pharma and Biotech

March 31, 2025

Industry Outlook 2025 – Part 2: Shifting Political Landscapes

January 30, 2025

Industry Outlook 2025 – Part 1: Through the Lens of a Service Provider

January 29, 2025

PharmaVoice’s Crystal Ball: The industry’s AI future

January 7, 2025

Drug Solutions Podcast: Realizing AI’s Potential

December 20, 2024

What is Pharmacovigilance?

August 30, 2024

Integrating Medical Devices into Pharmacovigilance Portfolios

July 11, 2024

Qinecsa featured in International Pharmaceutical Industry (IPI) editorial

July 11, 2024

Shaping the Future of Clinical Research Technology

July 10, 2024

Embracing a New Future-Ready Pharmacovigilance Ecosystem

July 10, 2024

Qinecsa shares latest innovations with industry media before DIA Global Annual Meeting 2024

June 13, 2024

Report: The Dynamics of Drug Safety in Small Pharma, Biotech, and Medical Devices

April 9, 2024

Fit-for-Future Sourcing for Pharmacovigilance: Embracing Change for Success

June 15, 2023

Transforming Data into Decisions

March 18, 2023

Qinecsa Pharmacovigilance Consulting Guide

December 13, 2022